Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Illumina

Illumina Earns Relative Strength Rating Upgrade

Illumina shows rising price performance, earning an upgrade to its IBD Relative Strength Rating

Investors Business Daily

Illumina Earns Relative Strength Rating Upgrade; Hits Key Benchmark

A Relative Strength Rating upgrade for Illumina shows improving technical performance.

Investors Business Daily

What You Need to Know Ahead of Illumina's Earnings Release

Illumina is expected to release its second-quarter earnings next month, analysts expect a double-digit earnings dip.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

3 Biopharma Stocks to Buy for Long-Term Growth

With the rising investment in personalized medicine research and development and growing clinical trials, the biopharma industry’s prospects appear promising. Hence, quality biotech stocks, Alnylam Pharmaceuticals (ALNY), Illumina (ILMN), and Gilead Sciences (GILD) with long-term growth might be solid buys. Read more….

StockNews.com

CrowdStrike, KKR, GoDaddy To Join S&P 500 In Quarterly Rebalance; Stocks Jump

CrowdStrike, KKR and GoDaddy will join the index before the open on June 24, as part of the quarterly rebalance.

Investors Business Daily

3 Biotech Stocks to Monitor for May Moves

The biotech industry is well poised to flourish, buoyed by its strong emphasis on technology-driven advancements to address complex medical challenges and government funding. Hence, quality biotech stocks Harmony Biosciences Holdings (HRMY), Illumina (ILMN), and Compugen (CGEN) could be ideal watchlist additions for May. Read more….

StockNews.com

Illumina CFO Goswami To Depart, Dhingra To Succeed

Illumina announces CFO transition as Mr. Goswami departs and Mr. Dhingra steps in to lead the company's financial management.

Top News

Read news from The Economist, FT, and more,
with one subscription

3 Biotech Stocks to Buy in 2024

The biotech industry is expected to grow rapidly due to rising demand for tailored treatments, increased R&D spending, and technological advancements. Therefore, fundamentally strong biotech stocks Harmony Biosciences Holdings (HRMY), Illumina (ILMN), and Halozyme Therapeutics (HALO) could be worth adding to your portfolio. Read on.

StockNews.com

Court Adviser Supports Curbing Powers Of GRAIL-Illumina Merger

Legal battle between GRAIL-M-A-ILLUMINA-EU and Illumina over merger powers may reshape industry landscape and set new precedents.

Top News

Stock Indexes Climb to Record Highs on Expectations for Fed Rate Cuts

The S&P 500 Index ($SPX ) (SPY ) this morning is up +0.48%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.49%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.90%. Stocks this morning extended Wednesday’s rally, with the S&P 500, Dow Jones Industrials,...

Barchart

3 B-Rated Biotech Stocks to Boost Your Bottom Line

The biotech industry’s growth prospects look promising due to innovative drugs and therapies, government initiatives, and technological advancements. Therefore, investors could consider buying fundamentally strong biotech stocks BioMarin Pharmaceutical (BMRN), Illumina (ILMN), and Harmony Biosciences (HRMY). These stocks are B-rated (Buy) in our proprietary rating system. Read on.

StockNews.com

3 Popular Biotech Stocks to Capitalize on Gains

The biotech industry’s rapid expansion is driven by rising healthcare sending, groundbreaking innovations, and strategic collaborations, propelling the growth of biopharma companies. Thus, it could be wise to invest in popular biotech stocks Illumina (ILMN), Shionogi (SGIOY), and Regeneron Pharmaceuticals (REGN) for substantial gains. Keep reading….

StockNews.com

3 Biotech Stocks to Buy for Profits Beyond 2024

The biotech industry is expected to deliver steady returns amid rising medical needs and increased research and development investment. Therefore, fundamentally strong biotech stocks Illumina (ILMN), Innoviva (INVA) and Puma Biotechnology (PBYI) might be ideal additions to your portfolio. Read on.

StockNews.com

3 Biotech Stocks Investors Are Watching for Future Growth

A wide range of applications across several sectors, supportive government initiatives, rapid technological advancements, and shifting market dynamics position the biotechnology industry for robust long-term growth. Given the industry’s bright outlook, biotech stocks MannKind (MNKD), Illumina (ILMN), and TG Therapeutics (TGTX) could be ideal watchlist additions for potential growth. Read…

StockNews.com

Get all your
news in one place.

100’s of premium titles.
One news app.

Barchart

Stocks Settle Mixed as 10-Year T-note Yield Stays Above 4%

What you need to know… The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed down -0.15%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.42%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.17%. Stocks on Tuesday settled mixed. Reduced expectations for...

Barchart

Stocks Fall Back after Monday’s Tech-Led Rally

What you need to know… The S&P 500 Index ($SPX ) (SPY ) today is down -0.42%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.70%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.36%. Stocks this morning are moderately lower as technology stocks...

Investors Business Daily

12 Stocks Turn $10,000 Into $313,671 In 12 Months

Talk about a strong finish. Investors who hung onto the top S&P 500 stocks this year ended up much richer for the effort.

Barchart

Stocks Rise on Dovish Fed Comment

What you need to know… The S&P 500 Index ($SPX ) (SPY ) today is up +0.41%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.36%. Stocks this morning are mildly higher, with the S&P...

Get all your
news in one place.

100’s of premium titles.
One news app.

Top News

Icahn Targets Illumina's Legacy Directors Removal

In a daring move, visionary investor Icahn seeks to oust Illumina's old guard, asserting fresh energy is needed in a vibrant, change-chasing letter.

Investors Business Daily

Illumina Ends Its Controversial Grail Battle With A Divestiture; Shares Rise

Illumina stock rose Monday after the company said it would divest its cancer detection outfit, Grail, following a lengthy court battle.

Investors Business Daily

Illumina To Sell Grail After U.S. Antitrust Ruling

Illumina said Sunday it will the sell cancer detection startup after a U.S. appeals court said the $7.1 billion deal violated antitrust laws,

Top News

Illumina Sheds Light, Divests its Cancer Tester, Grail

Illumina, a beacon in genetic science, is set to unfurl its stake in Grail-the stellar creator of cancer-detecting tests–in a dance of corporate divestiture.

Fortune

AI will live up to the hype and more unicorns will lose their horns: 10 health care predictions for 2024 from top investors

Top health care investors Bob Kocher and Bryan Roberts share their annual predictions for the sector–and how last year's list panned out.

Investors Business Daily

DNA-Reading Giant Illumina Crashes As Macro Pressures Guidance — Again

Illumina stock crashed Friday after the DNA-reading behemoth slashed its outlook as pressures continue to build on life sciences companies.

The Independent UK

EU orders biotech giant Illumina to unwind $7.1 billion purchase of cancer-screening company Grail

The European Union is ordering U.S. biotech giant Illumina to undo its $7.1 billion purchase of cancer-screening company Grail because it closed the deal without approval of regulators

1 2 3 4

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Wall Street Journal

641 stories

CrowdStrike

531 stories

SP Global Market Intelligence

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.